Die juristische Presseschau vom 12. bis 14. Juni 2021: Lockerungen der Maskenpflicht? / Berufsrecht und Legal Tech / Diskussionen um Vertragsverletzungsverfahren lto.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lto.de Daily Mail and Mail on Sunday newspapers.
(0)
LONDON, June 03, 2021 (GLOBE NEWSWIRE) COMPASS Pathways plc (Nasdaq: CMPS) ( COMPASS ), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has reported further results from a phase I study showing that its COMP360 psilocybin had no clinically-relevant negative effect on cognitive function, when administered to healthy adult volunteers with support from specially trained therapists.
The data) from the randomised, double-blind, placebo-controlled, phase I trial conducted at King s College London, will be presented today at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, by Dr James Rucker, Consultant Psychiatrist and Senior Clinical Lecturer in Psychopharmacology at King s College London s Institute of Psychiatry, Psychology and Neuroscience (IoPPN). Initial results from the study were published in December 2019. The results published today present a more in-depth analysis of cognitive
COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers
COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has reported further results from a phase I study showing that its COMP360 psilocybin had no clinically-relevant negative effect on cognitive function, when administered to healthy adult volunteers with support from specially trained therapists. The data from the randomised, …
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has reported further results from a phase I study showing that its COMP360 psilocybin had no clinically-relevant negative effect on cognitive function, when administered to healthy adult volunteers with support from specially trained therapists.
Εγκαίνια της αναβάθμισης του αεροδρομίου «Μακεδονία» στη Θεσσαλονίκη ka-business.gr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ka-business.gr Daily Mail and Mail on Sunday newspapers.
Operator
Good day, ladies and gentlemen, and welcome to the COMPASS Pathways first-quarter 2021 conference call. [Operator instructions]. As a reminder, this call is being recorded. I would now Like to introduce your host for today s conference, Stephen Schultz, senior vice president of investor relations.
You may begin.
Senior Vice President, Investor Relations
Thank you, operator, and welcome all of you, and thank you for joining us today for our first-quarter 2021 results call. Again, my name is Steve Schultz, senior vice president of investor relations at COMPASS Pathways. And today, I m joined by George Goldsmith, chairman and chief executive officer; and Piers Morgan, chief financial officer. George will begin today s call with a business update on our recent progress.